Richard A Bernstein

Professor, Neurology

Phone312/503-4394
Emailr-bernstein@northwestern.edu

Source: Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

Neurovascular Critical Care, Stroke, Stroke of unknown cause, stroke in young people, acute stroke therapy, atrial fibrillation, stem cell therapy for stroke.

Certifications and Licenses

	Vascular Neurology
	Neurology

Training Experience

1997	Internship, Mount Sinai Hospital, Illinois
2000	Residency, New York Presbyterian Hospital
2001	Fellowship, Univ. of CA-San Francisco Med. Ctr.

Education/Academic qualification

MD, PhD, Cornell University Medical College

… → 1996

Research interests

Stroke

Fingerprint

Dive into the research topics where Richard A Bernstein is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

7 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

1 Active
24 Finished

Stroke AF
Bernstein, R. A. & Caprio, F. Z.
Medtronic, Inc.
7/7/16 → 7/7/22
Project: Research project
Stroke Trials Network - Regional Coordinating Stroke Centers
Bernstein, R. A., Prabhakaran, S. & Roth, E. J.
National Institute of Neurological Disorders and Stroke
8/1/16 → 7/31/18
Project: Research project
Protocol #1160-189: Randomized, Double-Blind, Evaluation in Secondary Stroke Prevention Comparing the Efficacy and Safety of the Oral Thrombin Inhibitor Dabigatran Etexilate (110 mg or 150 mg, oral b.i.d.) Versus Acetylsalicylic Acid (100 mg oral q.d.) in
Bernstein, R. A. & Caprio, F. Z.
Boehringer Ingelheim Pharmaceuticals, Inc.
8/21/15 → 8/21/19
Project: Research project
A Phase III, Case Series Clinical Study of the Reversal of the Anticoagulant Effects of Dabigatran by Intravenous Administration of 5.0 g Idarucizumab (BI 655075) in Patients Treated with Dabigatran Etexilate who have Uncontrolled Bleeding or Require Emer
Bernstein, R. A.
Boehringer Ingelheim Pharmaceuticals, Inc.
4/6/15 → 4/6/18
Project: Research project
Study # D5134C00001: A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events with Ticagrelor Compared to Aspirin (ASA) in Patients with Acute Ischaemic Stroke or TIA [SOCRATES –Acute Stroke Or Transient IsChaemic Attack TReAted wi
Bernstein, R. A.
AstraZeneca Pharmaceuticals LP
4/23/14 → 4/22/17
Project: Research project

6449 Citations
79 Article
17 Review article
13 Letter
3 Comment/debate
More
- 2 Editorial
- 1 Short survey

Antithrombotic Treatment of Embolic Stroke of Undetermined Source: RE-SPECT ESUS Elderly and Renally Impaired Subgroups
Diener, H. C., Sacco, R. L., Easton, J. D., Granger, C. B., Bar, M., Bernstein, R. A., Brainin, M., Brueckmann, M., Cronin, L., Donnan, G., Gdovinová, Z., Grauer, C., Kleine, E., Kleinig, T. J., Lyrer, P., Martins, S., Meyerhoff, J., Milling, T., Pfeilschifter, W., Poli, S. & 4 others, Reif, M., Rose, D. Z., Šaňák, D. & Schäbitz, W. R., 2020, (Accepted/In press) In: Stroke. p. 1758-1765 8 p.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Scopus citations
The safety of oral anticoagulants registry (SOAR): A national, ED-based study of the evaluation and management of bleeding and bleeding concerns due to the use of oral anticoagulants
Hospital Quality Foundation, Jun 2020, In: American Journal of Emergency Medicine. 38, 6, p. 1163-1170 8 p.
Research output: Contribution to journal › Article › peer-review

Open Access
3 Scopus citations
Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis
Farrant, M., Easton, J. D., Adelman, E. E., Cucchiara, B. L., Barsan, W. G., Tillman, H. J., Elm, J. J., Kim, A. S., Lindblad, A. S., Palesch, Y. Y., Zhao, W., Pauls, K., Walsh, K. B., Martí-Fàbregas, J., Bernstein, R. A. & Johnston, S. C., Sep 4 2019, In: JAMA network open. 2, 9, p. e1910769
Research output: Contribution to journal › Article › peer-review

Open Access
Dabigatran for prevention of stroke after embolic stroke of undetermined source
Diener, H. C., Sacco, R. L., Donald Easton, J., Granger, C. B., Bernstein, R. A., Uchiyama, S., Kreuzer, J., Cronin, L., Cotton, D., Grauer, C., Brueckmann, M., Chernyatina, M., Donnan, G., Ferro, J. M., Grond, M., Kallmünzer, B., Krupinski, J., Lee, B. C., Lemmens, R., Masjuan, J. & 5 others, Odinak, M., Saver, J. L., Schellinger, P. D., Toni, D. & Toyoda, K., May 16 2019, In: New England Journal of Medicine. 380, 20, p. 1906-1917 12 p.
Research output: Contribution to journal › Article › peer-review
141 Scopus citations
Evaluation of the effect of sodium–glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial
on behalf of the EMPEROR-Reduced Trial Committees and Investigators, Executive Committee, National Coordinators, Consulting Statistician, Clinical Events Committee, Scientific Excellence Committee & Data Monitoring Committee, Oct 1 2019, In: European Journal of Heart Failure. 21, 10, p. 1270-1278 9 p.
Research output: Contribution to journal › Article › peer-review

Open Access
29 Scopus citations